Searched for
DOSTARLIMAB
GSK's Jemperli meets main goal in mid-stage rectal cancer trialGSK's cancer drug Jemperli met a key goal in a mid-stage trial. This drug targets a specific rectal cancer subtype affecting a small percen...- GSK India plans big 'reinvention', MD Bhushan Akshikar revealsGlaxoSmithKline Pharmaceuticals is planning a major comeback in India. The company aims to double its revenue to ₹8,000 crore within the ne...
- GSK re-enters India’s cancer drug marketGlaxoSmithKline Pharmaceuticals is re-entering India's oncology market with the launch of Jemperli and Zejula, precision therapies for gyna...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- UK woman declared cancer-free, thanks to new 'miracle drug'A civil servant in Wales has become the first person in the country to be prescribed a new drug, dostarlimab, for colorectal cancer. The 42...
- Tumour vanishes in all 12 rectal cancer patients in rare medical trial resultBesides their tumours disappearing completely, none of the participants reported any severe side-effects either, says the research paper pu...
- 'First time in history': Cancer vanishes from every patient's body in drug trialAccording to New York Times, in the small clinical trial conducted by Memorial Sloan Kettering Cancer Center, 18 patients took a drug calle...
- GSK, iTeos to develop cancer drug in up to $2 billion dealBoston-based iTeos will receive a $625 million upfront payment and is eligible to get up to $1.45 billion more if the programme meets certa...
Load More